Abstract
The poor prognosis of hepatocellular carcinoma (HCC) is mainly due to the development of invasion and metastasis. Recent data strongly suggests the important role of miRNAs in cancer progression, including invasion and metastasis. Here, we found miR-217 expression was much lower in highly invasive MHCC-97H HCC cells and metastatic HCC tissues. Restored miR-217 expression with miR-217 mimics inhibited invasion of MHCC-97H cells. Inversely, miR-217 inhibition enhanced the invasive ability of Huh7 and MHCC-97L cells. Mechanically, bioinformatics analysis combined with experimental analysis demonstrated E2F3 was a novel direct target of miR-217. Moreover, E2F3 protein level was positively associated with HCC metastasis and functional analysis confirmed the positive role of E2F3 in HCC cell invasion. Our findings suggest miR-217 function as a potential tumor suppressor in HCC progression and miR-217-E2F3 axis may be a novel candidate for developing rational therapeutic strategies.
Similar content being viewed by others
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576
Thomas MB, Jaffe D, Choti MM et al (2010) Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol 28:3994–4005
White NMA, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM (2010) Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol 8:75–84
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355
Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136:586–591
Iorio MV, Croce CM (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27:5848–5856
Valastyan S, Reinhardt F, Benaich N et al (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137:1032–1046
Yao J, Liang L, Huang S et al (2010) MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 51:846–856
Yang F, Yin Y, Wang F et al (2010) miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. Hepatology 51:1614–1623
Bai S, Nasser MW, Wang B et al (2009) MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 284:32015–32027
Tsai WC, Hsu PW, Lai TC et al (2009) MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49:1571–1582
Zhao WG, Yu SN, Lu ZH et al (2010) The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 31:1726–1733
Bracken AP, Ciro M, Cocito A, Helin K (2004) E2F target genes: unraveling the biology. Trends Biochem Sci 29:409–417
McClellan KA, Slack RS (2007) Specific in vivo roles for E2Fs in differentiation and development. Cell Cycle 6:2917–2927
Leone G, DeGregori J, Yan Z et al (1998) E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Gene Dev 12:2120–2130
Humbert PO, Verona R, Trimarchi JM et al (2000) E2F3 is critical for normal cellular proliferation. Genes Develop 14:690–703
Orlic M, Spencer CE, Wang L, Gallie BL (2006) Expression analysis of 6p22 genomic gain in retinoblastoma. Genes Chromosomes Cancer 45:72–82
Andre F, Job B, Dessen P et al (2009) Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 15:441–451
Feber A, Clark J, Goodwin G et al (2004) Amplification and overexpression of E2F3 in human bladder cancer. Oncogene 23:1627–1630
Oeggerli M, Tomovska S, Schraml P et al (2004) E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene 23:5616–5623
Foster CS, Falconer A, Dodson AR et al (2004) Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome. Oncogene 23:5871–5879
Borczuk A, Gorenstein L, Walter KL et al (2003) Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 163:1949–1960
Lu KH, Patterson AP, Wang L et al (2004) Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 10:3291–3300
Paulson QX, McArthur MJ, Johnson DG (2006) E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model. Cell Cycle 5:184–190
Noguchi S, Mori T, Otsuka Y et al (2012) Anti-oncogenic MicroRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells. J Biol Chem 287:11769–11777
Tazawa H, Tsuchiya N, Izumiya M, Nakagama H (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104:15472–15477
Ren XS, Yin MH, Zhang X et al (2013) Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. Cancer Lett. doi:10.1016/j.canlet.2013.10.031
Feng B, Wang R, Song HZ, Chen LB (2012) MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer 118:3365–3376
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Su, J., Wang, Q., Liu, Y. et al. miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3. Mol Cell Biochem 392, 289–296 (2014). https://doi.org/10.1007/s11010-014-2039-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-014-2039-x